Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Drug Delivery Devices Market is Segmented by Route of Administration (Injectable, Topical, Ocular, and Other Routes of Administration), by Application (Cancer, Cardiovascular, Diabetes, Infectious Diseases, and Other Applications), by End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Drug Delivery Devices Industry Overview

The drug delivery device market is moderately competitive and consists of several major players. Some of the companies currently dominating the market are Pfizer Inc., Novartis AG, F Hoffmann-La Roche Ltd, Johnson & Johnson, Bayer AG, Becton, Dickinson & Company, Altaris, Holozymes Inc. (Antares Pharma Inc.), GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd, Biocorp, Merck KGaA, West Pharmaceutical Services Inc., Molex (Philips Medisize), and Elcam Medical, among others. The major players have focused on strategic alliances, such as acquisitions, collaborations, investment in R&D activities, and launching new products, to secure their position in a competitive global market

Drug Delivery Devices Market Leaders

  1. Biocorp

  2. Becton, Dickinson and Company

  3. West Pharmaceutical Services Inc.

  4. Elcam Medical

  5. Holozymes Inc. (Antares Pharma Inc.)

  6. *Disclaimer: Major Players sorted in no particular order
Picture2.png